Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074437 · ClinicalTrials.gov registry record · Phase 2
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
A Phase 2 study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT01074437 is a Phase 2 study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 9 participants.
The verdict
NCT01074437, a Phase 2 study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids as compared to therapy with corticosteroids and placebo. We hypothesize that a two-month treatment period with propranolol plus corticosteroids is more effective at reducing infantile hemangioma size and vascularity when compared to corticosteroids used without propranolol for the same time period.
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Prednisolone (Corticosteroid)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01074437
The ClinicalTrials.gov registry entry for NCT01074437 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01074437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01074437 about?
NCT01074437 is a clinical study titled "Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)". This is a prospective randomized, double-blind study to compare the clinical efficacy of infantile hemangioma treatment using propranolol with corticosteroids as compared to therapy with corticosteroids and placebo. We hypothesize that a two-month treatment period with propranolol plus corticosteroi...
What is the current status of trial NCT01074437?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2010-02. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01074437?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Prednisolone (Corticosteroid) (DRUG).
Who is sponsoring clinical trial NCT01074437?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.